PRN Lorazepam (Ativan) Dosing Instructions
For anxiety or agitation in adults able to swallow: lorazepam 0.5-1 mg orally four times daily as needed, with a maximum of 4 mg in 24 hours. 1
Standard Adult Dosing
Oral Administration:
- Standard dose: 0.5-1 mg orally up to four times daily as needed
- Maximum daily dose: 4 mg in 24 hours
- Alternative route: Oral tablets can be used sublingually (off-label) 1
Elderly or Debilitated Patients:
- Reduced dose: 0.25-0.5 mg per dose
- Maximum daily dose: 2 mg in 24 hours 1
This dose reduction is critical in older adults, as they demonstrated significantly higher adverse event rates with standard dosing in recent geriatric emergency department studies 2.
Parenteral Dosing (When Unable to Swallow)
When oral administration is not feasible, switch to midazolam rather than parenteral lorazepam, as lorazepam is not the preferred parenteral benzodiazepine in current NICE guidelines for anxiety/agitation 1. However, if lorazepam must be used parenterally:
- IM/IV dose: 0.04-0.06 mg/kg has been established as effective 3
- Available concentrations: 2 mg/mL or 4 mg/mL 4
Clinical Context and Monitoring
When to use PRN dosing:
- PRN medications should not be prescribed routinely but reserved for specific indications 5
- Prescribe at a specific dose (not a range) 5
- Review daily and reassess need 5
- Document the specific indication before each administration 5
Key safety considerations:
- Respiratory depression risk: Particularly concerning with midazolam and other benzodiazepines; lorazepam carries this risk but to a lesser degree 5
- Paradoxical agitation: Occurs in approximately 10% of patients treated with benzodiazepines 6
- Combination therapy caution: Do not administer parenteral benzodiazepines until at least 2 hours after olanzapine due to respiratory depression risk 5
Formulation-Specific Adverse Events
Recent evidence shows formulation matters significantly for safety 2:
- Oral formulation: 2% adverse event rate (reference)
- Intramuscular: 15% adverse event rate (OR 7.63 vs oral)
- Intravenous: 19% adverse event rate (OR 10.17 vs oral)
This data strongly supports using oral formulation whenever possible, even sublingually if swallowing is difficult.
Comparative Safety Profile
In geriatric populations, lorazepam demonstrated a 16% overall adverse event rate, which was intermediate among benzodiazepines—lower than midazolam (53%) but higher than some antipsychotics 2. The drug showed particular value in its intermediate half-life, reducing accumulation risk compared to longer-acting agents 5.
Common Pitfalls to Avoid
- Avoid routine PRN ordering: Only prescribe when there is a specific, documented indication 5
- Don't use dose ranges: Specify exact doses to prevent confusion and dosing errors 5
- Monitor for tolerance: Regular use leads to tolerance, addiction, depression, and cognitive impairment 6
- Reassess frequently: Daily review is essential; lorazepam should be a short-term solution 5
- Watch for accumulation: Despite shorter half-life than diazepam, accumulation and over-sedation remain risks, particularly in elderly patients 5